Listen "Ep. 51 – Hemophilia: Patient Burden, Innovation, and Managed Care Strategy"
Episode Synopsis
In this episode of Unscripted, we continue our rare disease series with a focus on hemophilia and the substantial clinical, financial, and psychosocial burdens it places on patients and families. We speak with Janna Evans, Director of Pharmacy Sales Support at Blue Cross and Blue Shield of Texas, who discusses how health plans manage high-cost therapies, balance individualized patient needs with access requirements, and navigate prior authorization and step-therapy processes. She also highlights the need for better patient-reported outcomes, the day-to-day impact of the disease, and the broader considerations for employers and caregivers within managed care. This activity is supported by an independent medical education grant from Genentech Inc., and Pfizer Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Hemophilia Management.
More episodes of the podcast Unscripted - The AMCP Podcast
Ep. 47 – New ACG Guidelines for Crohn’s & Ulcerative Colitis: What Clinicians & Payers Need to Know
26/11/2025
Ep. 46 – Living With Parkinson’s Disease: A Patient Advocate’s Story of Diagnosis, Care, & Progress
25/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.